
Sign up to save your podcasts
Or


In the second of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the implications and limitations of the recent ACR–NPF guidelines for the management of psoriatic arthritis, together with key clinical trials that have been published since the guidelines were released.
Listen to part 1 here
Find more on Medicine Matters rheumatology
By Springer HealthcareIn the second of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the implications and limitations of the recent ACR–NPF guidelines for the management of psoriatic arthritis, together with key clinical trials that have been published since the guidelines were released.
Listen to part 1 here
Find more on Medicine Matters rheumatology